Regen BioPharma Inc (RGBP)

[Canadian Trader]

Bear in mind that the recent submission for additional info is actually an initiation of pre-clinical work to be conducted in a GLP-certified laboratory (see quote below for reference). This could take several months for them to complete. That being said, dCellVax has the opportunity to surpass HemaXellerate in the FDA process, provided the dCellVax IND is airtight. There's a good chance it is, given Dr. Min's involvement and the experiments in animal models and human cells that have already been conducted.

"Regen BioPharma Inc. (OTCBB: RGBP) announced today submission of a proposed experimental protocol to the FDA as part of ongoing discussions...

...

We are grateful for the cooperation of the FDA in working with our scientists in ensuring the appropriate preclinical experimentation is performed..."

Source: http://www.marketwired.com/press-release/regen-biopharma-submits-experimental-protocol-fda-hemaxellerate-aplastic-anemia-trial-otcbb-rgbp-1954889.htm